• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthpublic health
Europe

This drug could help counter monkeypox as the outbreak spreads to 3 more countries

By
Chloe Taylor
Chloe Taylor
Down Arrow Button Icon
By
Chloe Taylor
Chloe Taylor
Down Arrow Button Icon
May 25, 2022, 9:03 AM ET

British scientists have pointed to the oral medicine tecovirimat as a potential treatment for monkeypox, as the list of countries reporting unusual outbreaks of the disease continues to grow.

In a retrospective study published on Tuesday, researchers looked at treatments that had been given to monkeypox patients in previous outbreaks in the U.K., analyzing the efficacy of the drugs as well as any adverse effects they had had on the patients.

They studied records of seven patients who were diagnosed with monkeypox between 2018 and 2021.

Three of them had contracted monkeypox in the U.K. From an individual who had caught the virus overseas, while the rest of the patients had been infected in other countries.  

Five of the patients spent more than three weeks in isolation due to prolonged positive PCR test results.

One of the individuals in the study was treated with tecovirimat — an oral medicine used to treat smallpox, cowpox and monkeypox, all three of which belong to the orthopoxvirus family.

The patient was given 200mg of tecovirimat twice a day for two weeks, and had no adverse effects from the drug.

Compared with the other six patients, they had a shorter period of viral shedding and illness, and their hospitalization lasted just 10 days.

The FDA approved tecovirimat for use in the U.S. In 2018.

Meanwhile, three patients whose records were analyzed in the study were treated with a weekly 200mg dose of the antiviral brincidofovir — a drug used to treat smallpox.

However, they all developed elevated levels of liver enzymes during the course of treatment, which led doctors to end all three courses of brincidofovir early.

Monkeypox continues to spread

Three more countries — the UAE, Czech Republic and Slovenia — reported their first cases of monkeypox on Tuesday, as the virus continues to circulate outside of its usual hub in Africa.

Almost 20 countries, including the U.S., have now reported confirmed outbreaks of the virus, according to Reuters.

Several other countries are investigating suspected cases of monkeypox.

People who test positive for the virus are being kept in isolation, while U.K. Health officials are advising contacts of confirmed cases to self-isolate for three weeks.

Health experts have sustained a position that the risk to the general public is low, with the WHO describing the outbreak as “containable.”

Monkeypox is a disease that usually spreads to humans from animals in parts of Africa.

While human-to-human transmission is rare, its is possible if an infected person has close or direct contact with someone else.

The current outbreak in countries where monkeypox is not endemic has predominantly been reported in men who identify as gay or bisexual.

While sexual contact can spread the virus due to close contact, it is not a sexually transmitted infection.

Health officials have stressed that people of any sexual orientation can contract the virus.

Symptoms are usually mild and include headaches, fever and a rash. People generally make a full recovery within a few weeks.

Sign up for the Coins2Day Features email list so you don’t miss our biggest features, exclusive interviews, and investigations.

About the Author
By Chloe Taylor
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.